logo

For the Inventor, By the Inventor

Kalamazoo, MI, United States of America

Harvey I Skulnick

This inventor holds 24 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: The Upjohn Co., Pharmacia & Upjohn Company, Other. Active years: 1976-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harvey I Skulnick. Retrieved from https://idiyas.com/inventor/harvey-i-skulnick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 216(Granted Patents)


Location History:

  • Oshtemo, MI (US) (1984)
  • Oshtemo Township, Kalamazoo County, MI (US) (1979 - 1989)
  • Kalamazoo, MI (US) (1976 - 2005)

Company Filing History:

goldMedal17 out of 2,170 
 
The Upjohn Co.
 patents
silverMedal5 out of 523 
 
Pharmacia & Upjohn Company
 patents
bronzeMedal2 out of 834,513 
Other
 patents

Years Active: 1976-2005

Loading Chart...
Areas of Expertise:
Taxol Derivative
Retroviral Infections
Tetronic Acids
Antineoplastic
Pyranone Compounds
Aryl Pyrimidines
6-Aryluracils
Nucleosides
Hypertension
Angiostatic Steroids
Substituted Pyrimidines
24 patents (USPTO):Explore Patents
1. 6911549 - Method of preparing a taxol derivative (2005-06-28),
2. 6169181 - Compounds useful to treat retroviral infections (2001-01-02),
3. 6060600 - Substituted tetronic acids useful for treating HIV and other retroviruses (2000-05-09),
4. 5977169 - Substituted tetronic acids useful for treating HIV and other retroviruses (1999-11-02),
5. 5965739 - .DELTA..sup.6,7 -taxols antineoplastic use and pharmaceutical (1999-10-12),
6. 5852195 - Pyranone compounds useful to treat retroviral infections (1998-12-22),
7. 5686486 - 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl�b!pyran-2-ones (1997-11-11),
8. 5556878 - .DELTA..sup.6,7 -taxols antineoplatic use and pharmaceutical (1996-09-17),
9. 5434157 - 6-aryl pyrimidine compounds and method for treating viral infections and (1995-07-18),
10. 4975537 - .DELTA..sup.9(11) -angiostatic steroids (1990-12-04),
11. 4795812 - 4-substituted-6-aryl-pyrimidine compounds (1989-01-03),
12. 4593096 - Novel compounds and process for treating hypertension (1986-06-03),
13. 4593030 - Use of 6-aryluracils as antiinflammatory and antiarthritic agents (1986-06-03),
14. 4578466 - Processes for the preparation of 6-aryluracils (1986-03-25),
15. 4521599 - Process for the preparation of 1,3-oxazine-4-ones (1985-06-04),

Title: **Harvey I Skulnick: Innovator in Pharmaceutical Chemistry**

Introduction

Harvey I Skulnick, based in Kalamazoo, MI, has made significant contributions to the field of pharmaceutical chemistry, demonstrated through his impressive portfolio of 24 patents. His inventions primarily focus on developing compounds that target various forms of cancer and retroviral infections, showcasing his dedication to advancing medical treatments.

Latest Patents

Among his latest inventions are innovative methods of preparing taxol derivatives. This invention provides 7-deoxy-taxol analogs that are effective against cancers such as human ovarian cancer, breast cancer, malignant melanoma, lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia. Additionally, he has developed compounds useful for treating retroviral infections, which include pyran-2-ones and their derivatives that inhibit retroviruses in infected mammalian cells. These patents reflect Skulnick's commitment to creating valuable therapeutic solutions.

Career Highlights

Harvey I Skulnick's career includes notable positions at esteemed pharmaceutical companies, such as The Upjohn Company and Pharmacia & Upjohn Company. His work has not only advanced scientific knowledge but has also contributed to the formulation of effective drugs that have an impact on public health.

Collaborations

Throughout his illustrious career, Skulnick has worked alongside distinguished professionals, including Wendell Wierenga and Paul A Aristoff. These collaborations have played a crucial role in fostering innovation and expediting the development of new pharmaceutical compounds.

Conclusion

Harvey I Skulnick's contributions to pharmaceutical chemistry and his groundbreaking patents underscore his role as a leading inventor. His ongoing efforts to combat cancer and retroviral infections render him a significant figure in the field, inspiring future innovations in medical research and drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…